Nova Leap Health Corp. Announces Results of Special Meeting

Press Release - July 20, 2017 (1694 downloads)

HALIFAX, NOVA SCOTIA July 20, 2017 – Nova Leap Health Corp. (the “Company”) (TSXV: NLH) is pleased to announce that at the special meeting of shareholders held on July 19, 2017 (“Meeting”), the shareholders approved an amendment to the Company’s articles of incorporation to permit the directors to appoint one or more additional directors to hold office for a term expiring not later than the close of the next annual meeting of shareholders in accordance with the Canada Business Corporations Act.

Subject to final acceptance by the TSX Venture Exchange, the Company intends to appoint Wayne Myles to the board of directors.  A further announcement will be made when Wayne Myles is appointed.

For further information:

Christopher Dobbin, Director, President and CEO Nova Leap Health Corp.

T: 902.401.9480   F: 902.482.5177

Email :


Cautionary Statement:

This press release may contain forward-looking information, such as statements regarding the planned appointment of Mr. Myles. This information is based on current expectations and assumptions that are subject to risks and uncertainties that are difficult to predict, including risks relating to the approval of the TSX Venture Exchange. Actual results may differ materially from results suggested in any forward-looking information. The Company does not assume any obligation to update forward-looking information in this release, or to update the reasons why actual results could differ from those reflected in the forward-looking information unless and until required by applicable securities laws. Additional information identifying risks and uncertainties is contained in the filings made by the Company with Canadian securities regulators, which filings are available at

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

(Not for distribution to US wire services or for dissemination in the United States of America)


7071 Bayers Road, Suite 3006
Halifax, Nova Scotia Canada B3L 2C2


Chris Dobbin
President & CEO